25 results
8-K
EX-3.1
RVNC
Revance Therapeutics Inc
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
. Organization
ARTICLE V OFFICERS
Section 28. Officers Designated
Section 29. Tenure And Duties Of Officers.
Section 30. Delegation Of Authority
Section 31 … be fixed by or in the manner designated by the Board of Directors.
Section 29. Tenure And Duties Of Officers.
(a) General. All officers shall hold
8-K
EX-3.1
RVNC
Revance Therapeutics Inc
22 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
.
Section 27. Organization.
ARTICLE V OFFICERS
Section 28. Officers Designated.
Section 29. Tenure And Duties Of Officers.
Section 30. Delegation … be fixed by or in the manner designated by the Board of Directors.
Section 29. Tenure And Duties Of Officers.
(a) General. All officers shall hold office
PRE 14A
brcaxs v2
12 Mar 21
Preliminary proxy
4:13pm
8-K
5erernh jvnz4z
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.1
fmliyt8
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.2
q411g4b29oj8w ye908
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.1
qvflafsp7ilwyu x9z0n
15 Oct 19
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne
8:17am
10-K
qv280j5
28 Mar 14
Annual report
12:00am
424B4
ahdmgxfy gax8os2h4
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
EX-10.9
k7jkd9c
31 Dec 13
IPO registration
12:00am
S-1
EX-3.3
35kmks 8hjw67k7u
31 Dec 13
IPO registration
12:00am